Product cited in:
Salomon, Steinberg, Koren-Morag et al.: "Reduced incidence of ischemic stroke in patients with severe factor XI deficiency." in: Blood, Vol. 111, Issue 8, pp. 4113-7, 2008 (PubMed).
Samuel, Cheng, Riley et al.: "Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 40, pp. 15693-8, 2007 (PubMed).
Yang, Flanders, Kim et al.: "Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events." in: American journal of clinical pathology, Vol. 126, Issue 3, pp. 411-5, 2006 (PubMed).
Eichinger, Schönauer, Weltermann et al.: "Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism." in: Blood, Vol. 103, Issue 10, pp. 3773-6, 2004 (PubMed).
Berliner, Rybicki, Kaplan et al.: "Elevated levels of Factor XI are associated with cardiovascular disease in women." in: Thrombosis research, Vol. 107, Issue 1-2, pp. 55-60, 2002 (PubMed).
von dem Borne, Meijers, Bouma: "Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis." in: Blood, Vol. 86, Issue 8, pp. 3035-42, 1995 (PubMed).
Fujikawa, Chung, Hendrickson et al.: "Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein." in: Biochemistry, Vol. 25, Issue 9, pp. 2417-24, 1986 (PubMed).
Asakai, Davie, Chung: "Organization of the gene for human factor XI." in: Biochemistry, Vol. 26, Issue 23, pp. 7221-8, 1988 (PubMed).